Crossmark

Fully sialylated alpha-chain of complement 4-binding protein (A2160): a novel prognostic marker for epithelial ovarian carcinoma

Crossref DOI link: https://doi.org/10.1007/s00404-018-4658-z

Published Online: 2018-01-16

Published Print: 2018-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Matsuo, Koji

Tanabe, Kazuhiro

Ikeda, Masae

Shibata, Takeo

Kajiwara, Hiroshi

Miyazawa, Masaki

Miyazawa, Mariko

Hayashi, Masaru

Shida, Masako

Hirasawa, Takeshi

Roman, Lynda D.

Mikami, Mikio
License Information

Text and Data Mining valid from 2018-01-16
More Information

Article History

Received: 27 July 2017

Accepted: 9 January 2018

First Online: 16 January 2018

Compliance with ethical standards

:

: The authors have declared that no conflicts of interest exist.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.